Follow The Filings

EHTH Ehealth Inc.

Financials, filed as EHEALTH INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.3%
  • $2.2M

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Palo Alto Investors). Not free-float ownership.

  1. Palo Alto Investors 0.31%

Who owns EHTH

Sorted by value, long equity only, as of 2026 Q2.

History
Palo Alto Investors 0.31% Hold 1,482,797 $2.2M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EHTH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EHTH insider trades
  • $298K bought by 2 insiders
  • None no sales outside a trading plan
  • $110K sold by 1 insider under 10b5-1 plans
  1. Francis S Soistman Jr. Director
    Planned sale
    $28K 40,612 shares at $0.6900 4% of stake
    Traded Oct 1–2 Filed Oct 2
    ↗
  2. Francis S Soistman Jr. Director
    Planned sale
    $82K 74,593 shares at $1.10 6.8% of stake
    Traded Aug 31–Sep 1 Filed Sep 2
    ↗
  3. John Joseph Dolan CFO
    Buy
    $38K 25,000 shares at $1.53 +14% to stake
    Traded Mar 6 Filed Mar 9
    ↗
  4. Derrick A Duke CEO
    Buy
    $259K 187,969 shares at $1.38 +63% to stake
    Traded Feb 27 Filed Mar 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 share withholdings for taxes and 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 3.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $452.87M $532.41M $554.01M
Gross profit * $451.1M $208.46M $240.77M
Gross margin * 99.6% 39.2% 43.5%
Net income -$28.21M $10.06M $40.04M
Net margin * -6.2% 1.9% 7.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $382.35M $354.48M $334.35M
Total non-current assets * $730.99M $800.95M $928.12M
Total assets $1.11B $1.16B $1.26B
Total current liabilities $78.54M $96.01M $99.07M
Total non-current liabilities * $130.72M $133.48M $189.75M
Total equity $606.03M $588.43M $591.6M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$6.69M -$18.37M -$25.34M
Cash from investing -$15.89M -$48.42M $25.43M
Cash from financing -$6.22M -$9.67M $34.29M
Net change in cash -$28.83M -$76.52M $34.53M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.